Dr. Nicholas M. Siebers

Internal Medicine
5249 E Terrace Dr, 
Madison, WI 
5249 E Terrace Dr, 
Madison, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nicholas Siebers is a primary care provider, practicing in Internal Medicine in Madison, Wisconsin.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in WI
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

5249 E Terrace Dr, Madison, WI 53718

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3841136 in Healthy and Overweight Participants
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3841136 in Healthy and Overweight Participants
Enrollment Status: Completed
Publish Date: April 01, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Study of the Absorption, Metabolism, and Excretion of [14C]-KBP-5074 Following a Single Oral Dose in Healthy Male Subjects
A Phase 1, Open-label, Study of the Absorption, Metabolism, and Excretion of [14C]-KBP-5074 Following a Single Oral Dose in Healthy Male Subjects
Enrollment Status: Completed
Publish Date: February 23, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Bioequivalence Study of Injections of Mirikizumab Solution Using an Investigational 1-mL Pre-Filled Syringe and an Investigational 1-mL Autoinjector in Healthy Participants
A Bioequivalence Study of Injections of Mirikizumab Solution Using an Investigational 1-mL Pre-Filled Syringe and an Investigational 1-mL Autoinjector in Healthy Participants
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Randomized Study to Investigate Injection-Site Pain Following Subcutaneous Injections of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation Using a Pre-filled Syringe in Healthy Subjects
A Randomized Study to Investigate Injection-Site Pain Following Subcutaneous Injections of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation Using a Pre-filled Syringe in Healthy Subjects
Enrollment Status: Terminated
Publish Date: November 30, 2022
Intervention Type: Biological
Study Phase: Phase 1
An Open-label Trial to Evaluate the Absorption, Metabolism, and Excretion of a Single Dose of [14C]-Tavapadon in Healthy Adult Male Subjects at Steady State
An Open-label Trial to Evaluate the Absorption, Metabolism, and Excretion of a Single Dose of [14C]-Tavapadon in Healthy Adult Male Subjects at Steady State
Enrollment Status: Completed
Publish Date: November 17, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, 4-Period Cross-Over Study Assessing the Duration of Effect of Lasmiditan on Simulated Driving Performance in Healthy Volunteers
A Phase I, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, 4-Period Cross-Over Study Assessing the Duration of Effect of Lasmiditan on Simulated Driving Performance in Healthy Volunteers
Enrollment Status: Completed
Publish Date: January 13, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects
A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects
Enrollment Status: Completed
Publish Date: December 02, 2019
Intervention Type: Drug
Study Phase: Phase 1
Safety, Tolerability, and Pharmacokinetics of Lasmiditan When Co-administered With Topiramate in Healthy Subjects
Safety, Tolerability, and Pharmacokinetics of Lasmiditan When Co-administered With Topiramate in Healthy Subjects
Enrollment Status: Completed
Publish Date: November 27, 2019
Intervention Type: Drug
Study Phase: Phase 1
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Enrollment Status: Completed
Publish Date: November 26, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 8 Less Clinical Trials

7 Total Publications

Pharmacokinetics, metabolism, and excretion of [14C]-valemetostat in healthy male participants, and in vitro plasma protein binding.
Pharmacokinetics, metabolism, and excretion of [14C]-valemetostat in healthy male participants, and in vitro plasma protein binding.
Journal: Cancer chemotherapy and pharmacology
Published: November 01, 2024
Similar Doctors
Alok Srivastava
Expertise in
21
conditions
Dr. Alok Srivastava
Internal Medicine
Expertise in
21
conditions
Dr. Alok Srivastava
Internal Medicine

Aurora Internal Medicine

818 Forrest Ln, 
Waterford, WI 
 (58.8 miles away)
262-514-3700
Languages Spoken:
English
See accepted insurances

Alok Srivastava is a primary care provider, practicing in Internal Medicine in Waterford, Wisconsin. Dr. Srivastava is highly rated in 21 conditions, according to our data. His top areas of expertise are Hemophilia A, Blood Clots, Beta Thalassemia, Bone Marrow Aspiration, and Endovascular Embolization.

Expertise in
7
conditions
Dr. Sanjay J. Asthana
Geriatrics | General Practice | Internal Medicine
Expertise in
7
conditions
Dr. Sanjay J. Asthana
Geriatrics | General Practice | Internal Medicine

University Of Wisconsin Medical Foundation Inc

2880 University Ave, 
Madison, WI 
 (7.6 miles away)
608-263-9339
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sanjay Asthana is a primary care provider, practicing in Geriatrics and Internal Medicine in Madison, Wisconsin. Dr. Asthana is highly rated in 7 conditions, according to our data. His top areas of expertise are Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, Memory Loss, and Hormone Replacement Therapy (HRT). Dr. Asthana is currently accepting new patients.

Expertise in
3
conditions
Dr. Thomas S. Hyzer
Internal Medicine
Expertise in
3
conditions
Dr. Thomas S. Hyzer
Internal Medicine
4410 Regent St, 
Madison, WI 
 (8.2 miles away)
608-233-9746
Languages Spoken:
English

Thomas Hyzer is a primary care provider, practicing in Internal Medicine in Madison, Wisconsin. Dr. Hyzer is highly rated in 3 conditions, according to our data. His top areas of expertise are Short Bowel Syndrome, Small Bowel Bacterial Overgrowth, and Malnutrition.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Siebers's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile